A detailed history of American Century Companies Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, American Century Companies Inc holds 1,850,084 shares of EW stock, worth $137 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,850,084
Previous 2,082,961 11.18%
Holding current value
$137 Million
Previous $192 Million 36.55%
% of portfolio
0.07%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$59.7 - $93.78 $13.9 Million - $21.8 Million
-232,877 Reduced 11.18%
1,850,084 $122 Million
Q2 2024

Aug 07, 2024

BUY
$84.3 - $94.31 $3.65 Million - $4.08 Million
43,247 Added 2.12%
2,082,961 $192 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $5.56 Million - $7.32 Million
-76,615 Reduced 3.62%
2,039,714 $195 Million
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $16.8 Million - $21.1 Million
-271,810 Reduced 11.38%
2,116,329 $161 Million
Q3 2023

Nov 30, 2023

BUY
$69.28 - $93.38 $165 Million - $223 Million
2,388,139 New
2,388,139 $165 Billion
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $14.1 Million - $16.3 Million
-172,810 Reduced 6.84%
2,352,010 $222 Million
Q1 2023

May 11, 2023

SELL
$74.26 - $84.51 $134 Million - $152 Million
-1,803,547 Reduced 41.67%
2,524,820 $209 Million
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $32.3 Million - $41.4 Million
473,547 Added 12.28%
4,328,367 $323 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $793,799 - $1.03 Million
9,637 Added 0.25%
3,854,820 $319 Million
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $4.17 Million - $6.19 Million
-48,244 Reduced 1.24%
3,845,183 $366 Million
Q1 2022

May 11, 2022

SELL
$101.96 - $128.34 $23.8 Million - $30 Million
-233,665 Reduced 5.66%
3,893,427 $458 Million
Q4 2021

Feb 07, 2022

SELL
$106.37 - $130.68 $31.8 Million - $39.1 Million
-298,865 Reduced 6.75%
4,127,092 $535 Million
Q3 2021

Nov 10, 2021

BUY
$102.91 - $122.75 $18.9 Million - $22.6 Million
184,057 Added 4.34%
4,425,957 $501 Million
Q2 2021

Aug 05, 2021

BUY
$83.84 - $104.76 $3.24 Million - $4.05 Million
38,704 Added 0.92%
4,241,900 $439 Million
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $942,586 - $1.09 Million
-11,980 Reduced 0.28%
4,203,196 $352 Million
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $25.9 Million - $33 Million
-361,607 Reduced 7.9%
4,215,176 $385 Million
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $2.75 Million - $3.58 Million
-40,907 Reduced 0.89%
4,576,783 $365 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $177 Million - $237 Million
3,075,819 Added 199.49%
4,617,690 $319 Million
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $8.89 Million - $13.7 Million
169,715 Added 12.37%
1,541,871 $291 Million
Q4 2019

Feb 12, 2020

SELL
$71.7 - $82.09 $17.4 Million - $20 Million
-243,122 Reduced 15.05%
1,372,156 $320 Million
Q3 2019

Nov 13, 2019

BUY
$61.55 - $75.43 $21.1 Million - $25.8 Million
342,246 Added 26.88%
1,615,278 $355 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $33.9 Million - $39.2 Million
-608,195 Reduced 32.33%
1,273,032 $235 Million
Q1 2019

May 14, 2019

BUY
$47.89 - $64.05 $5.98 Million - $8 Million
124,929 Added 7.11%
1,881,227 $0
Q4 2018

Feb 13, 2019

SELL
$46.41 - $56.94 $6.34 Million - $7.78 Million
-136,684 Reduced 7.22%
1,756,298 $269 Million
Q3 2018

Nov 02, 2018

SELL
$45.7 - $58.03 $24.8 Million - $31.5 Million
-542,858 Reduced 22.29%
1,892,982 $330 Million
Q2 2018

Aug 08, 2018

SELL
$42.45 - $51.3 $15 Million - $18.2 Million
-353,881 Reduced 12.69%
2,435,840 $355 Million
Q1 2018

May 03, 2018

BUY
$37.19 - $47.45 $27.4 Million - $34.9 Million
736,465 Added 35.87%
2,789,721 $389 Million
Q4 2017

Feb 02, 2018

SELL
$33.79 - $39.39 $5.77 Million - $6.73 Million
-170,754 Reduced 7.68%
2,053,256 $231 Million
Q3 2017

Nov 01, 2017

BUY
$36.29 - $38.83 $80.7 Million - $86.4 Million
2,224,010
2,224,010 $243 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.